19-05-2025
Accretion Pharmaceuticals IPO Allotment Today: A Step-By-Step Guide To Check Status Online, Know Latest GMP
Last Updated:
Unlisted shares of Accretion Pharmaceuticals Ltd are currently trading at Rs 101 apiece, which is zero premium (GMP) over the IPO price of Rs 101.
Accretion Pharma IPO Allotment Today: The share allotment of the Accretion Pharmaceuticals IPO, which closed on May 16 with a 7.67 times subscription, is scheduled to be finalised today, Monday, May 19. Once finalised, investors will start getting bank debit messages. They can also check the IPO allotment status online on registrar Kfin Technologies Ltd's website as well as on the NSE's portal.
The NSE SME IPO, which was open for public subscription between May 14 and May 16, received a 7.67 times subscription garnering bids for 1,98,42,000 shares as against 25,87,200 shares on offer.
The retail and NII participation stood at 10.54 times and 4.28 times, respectively. Its qualified institutional buyer (QIB) category got a 12.14 times subscription.
The IPO allotment is expected to take place today, May 19, in the evening. Once allotted, investors can check the allotment status by following these steps:
Step 3: Enter 'application number/ CAF No.', 'Demat Account', or 'PAN number'.
According to market observers, unlisted shares of Accretion Pharmaceuticals Ltd are currently trading at Rs 101 apiece, which is zero premium (GMP) over the IPO price of Rs 101. Its listing is scheduled to take place on May 21 on both the NSE Emerge platform.
The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price.
Accretion Pharmaceuticals IPO: More Details
The Rs 29.75-crore Accretion Pharmaceuticals IPO is entirely a fresh issue of 29.46 lakh shares. Its price band was fixed at Rs 101 per share.
The bidding started on May 14, 2025 and closed on May 16, 2025. The IPO allotment is scheduled to be finalised on Monday, May 19, 2025. Its shares will be list on the NSE SME on Wednesday, May 21, 2025.
Accretion Pharmaceuticals Limited, which was set up in 2012, is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products. It also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).
Jawa Capital Services Private Limited is the book-running lead manager of the Accretion Pharmaceuticals IPO, while Kfin Technologies Limited is the registrar for the market maker for Accretion Pharmaceuticals IPO is Gretex Share Broking Private Limited.
First Published:
May 19, 2025, 10:29 IST
